Amicus Therapeutics, Inc. (FOLD)
NASDAQ: FOLD · Real-Time Price · USD
9.90
-0.05 (-0.50%)
At close: Dec 5, 2025, 4:00 PM EST
9.99
+0.09 (0.91%)
After-hours: Dec 5, 2025, 6:28 PM EST
Amicus Therapeutics Employees
Amicus Therapeutics had 499 employees as of December 31, 2024. The number of employees decreased by 18 or -3.48% compared to the previous year.
Employees
499
Change (1Y)
-18
Growth (1Y)
-3.48%
Revenue / Employee
$1,199,808
Profits / Employee
-$28,178
Market Cap
3.05B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
FOLD News
- 24 days ago - Amicus Therapeutics: Moving Towards Consistent Profitability - Seeking Alpha
- 25 days ago - Amicus Therapeutics, Inc. (FOLD) Presents at UBS Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 4 weeks ago - Amicus Therapeutics, Inc. (FOLD) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Amicus Therapeutics Announces Third Quarter 2025 Financial Results and Corporate Updates - GlobeNewsWire
- 5 weeks ago - Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2025 - GlobeNewsWire
- 6 weeks ago - Amicus Therapeutics to Announce Third Quarter 2025 Financial Results on November 4, 2025 - GlobeNewsWire
- 6 weeks ago - Amicus Therapeutics: Turning The Corner To Profitability With 2 Developing Therapies - Seeking Alpha
- 2 months ago - 3 Of My Favorite Biotech Stocks Under $10 - Seeking Alpha